DAN PUCKETT
CIK 1602773 · Chief Financial Officer · last filed 2026-06-10
DAN PUCKETT is a Chief Financial Officer who has filed 65 SEC Form 4 insider transactions across 2 companies since 2019. The most recent filing, for PRCT, was dated Jun 10, 2026. Across all open-market trades the lifetime net is −$23.6M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $156.4K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$156.4K
2
65
-$23.59M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| PRCT | Director | 8,791 | $17.79 | $156.4K | $0 | 2 | 2026-06-10 |
| Shockwave Medical, Inc. (SWAV) Delisted | Chief Financial Officer | 21,005 | $334.75 | $7.03M | -$23.59M | 57 | 2024-02-06 |
Recent Filings
65 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-10 | PRCT | Grant (A) | +3,315 | $0 | EDGAR |
| 2026-03-09 | PRCT | Grant (A) | +5,476 | $0 | EDGAR |
| 2024-02-20 | — | Notice (144) | −3,628 | -$952.9K | EDGAR |
| 2024-02-06 | Shockwave Medical, Inc. (SWAV) Delisted | Mixed | −6,727 | -$1.54M | EDGAR |
| 2024-02-05 | — | Notice (144) | −3,229 | -$754.1K | EDGAR |
| 2024-02-02 | Shockwave Medical, Inc. (SWAV) Delisted | Sell (S) | −3,406 | -$782.6K | EDGAR |
| 2024-02-01 | — | Notice (144) | −3,406 | -$770.6K | EDGAR |
| 2024-01-17 | Shockwave Medical, Inc. (SWAV) Delisted | Mixed | +3,406 | -$450.2K | EDGAR |
| 2023-12-11 | Shockwave Medical, Inc. (SWAV) Delisted | Sell (S) | −200 | -$34.8K | EDGAR |
| 2023-12-08 | — | Notice (144) | −200 | -$35.0K | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.